Skip to main content

CASI Pharmaceuticals, Inc. (CASI)

NASDAQ: CASI · Delayed Price · USD
0.879
0.019 (2.23%)
At close: Dec 8, 2021 4:00 PM
0.893
0.014 (1.581%)
After-hours:Dec 8, 2021 4:57 PM EST
Market Cap122.90M
Revenue (ttm)25.83M
Net Income (ttm)-45.25M
Shares Out139.80M
EPS (ttm)-0.34
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume748,416
Open0.869
Previous Close0.860
Day's Range0.847 - 0.900
52-Week Range0.760 - 3.900
Beta0.37
AnalystsStrong Buy
Price Target4.45 (+406.2%)
Earnings DateNov 12, 2021

About CASI

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. The company offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma, which has completed Phase I studies in China. It also provides CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute ly...

IndustryBiotechnology
IPO DateJun 11, 1996
CEOWei-Wu He
Employees144
Stock ExchangeNASDAQ
Ticker SymbolCASI
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for CASI stock is "Strong Buy." The 12-month stock price forecast is 4.45, which is an increase of 406.20% from the latest price.

Price Target
$4.45
(406.20% upside)
Analyst Consensus: Strong Buy

News

CASI Pharmaceuticals To Present At Jefferies London Healthcare Conference

ROCKVILLE, Md., and BEIJING, Nov. 15, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics a...

3 weeks ago - PRNewsWire

CASI Pharmaceuticals Announces Third Quarter 2021 Financial Results

ROCKVILLE, Md. and BEIJING, Nov. 12, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...

3 weeks ago - PRNewsWire

CASI Pharmaceuticals Earnings Preview

CASI Pharmaceuticals (NASDAQ:CASI) is set to give its latest quarterly earnings report on Friday, 2021-11-12. Here's what investors need to know before the announcement.

3 weeks ago - Benzinga

CASI Pharmaceuticals Partner, BioInvent, To Present Further Positive Clinical Data On BI-1206 At ASH 2021

ROCKVILLE, Md., and BEIJING, Nov. 5, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics an...

1 month ago - PRNewsWire

CASI Pharmaceuticals To Report Third Quarter 2021 Financial Results And Host Conference Call November 12, 2021

ROCKVILLE, Md. and BEIJING, Nov. 2, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and...

1 month ago - PRNewsWire

CASI Pharmaceuticals, Inc. (CASI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

CASI Pharmaceuticals, Inc. (CASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

CASI Pharmaceuti­­­cals Announces Partner Juventas Completion Of Series C Financing Of $63 Million (RMB410 Million) F...

ROCKVILLE, Md. and BEIJING, Oct. 25, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics an...

1 month ago - PRNewsWire

CASI Pharma (CASI) Sees Hammer Chart Pattern: Time to Buy?

CASI Pharma (CASI) has been struggling lately, but the selling pressure may be coming to an end soon.

2 months ago - Zacks Investment Research

Penny Stocks For Your Biotech Watch List In September 2021

Penny stocks that may be worth watching right now. The post Penny Stocks For Your Biotech Watch List In September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:AMPECFMSCLVS
2 months ago - PennyStocks

Trending Penny Stocks To Buy For Under $3 Right Now

Are these penny stocks worth the risk? The post Trending Penny Stocks To Buy For Under $3 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:SOSXERS
3 months ago - PennyStocks

CASI Pharmaceuticals, Inc. (CASI) Reports Q2 Loss, Tops Revenue Estimates

CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 44.44% and 16.46%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

CASI Pharmaceuticals Announces Second Quarter 2021 Financial Results

ROCKVILLE, Md. and BEIJING, Aug. 12, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics an...

3 months ago - PRNewsWire

CASI Pharmaceuticals To Report Second Quarter 2021 Financial Results And Host Conference Call August 12, 2021

ROCKVILLE, Md. and BEIJING, Aug. 10, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics an...

3 months ago - PRNewsWire

Analysts Estimate CASI Pharmaceuticals, Inc. (CASI) to Report a Decline in Earnings: What to Look Out for

CASI Pharmaceuticals, Inc. (CASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

CASI Pharmaceuticals Announces Dosing Of First Patient Of CID-103 In Phase 1 Clinical Trial For Relapsed Or Refractor...

ROCKVILLE, Md. and BEIJING, June 10, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics an...

5 months ago - PRNewsWire

CASI Pharmaceuticals, Inc. To Participate In Jefferies Virtual Healthcare Conference

ROCKVILLE, Md. and BEIJING, May 27, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and...

6 months ago - PRNewsWire

CASI Pharmaceuticals: Q1 Earnings Insights

Shares of CASI Pharmaceuticals (NASDAQ:CASI) moved higher by 2.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 22.22% year over year to ($0.11),...

6 months ago - Benzinga

CASI Pharmaceuticals Announces First Quarter 2021 Financial Results

ROCKVILLE, Md. and BEIJING, May 13, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and...

6 months ago - PRNewsWire

CASI Pharmaceuticals To Report First Quarter 2021 Financial Results And Host Conference Call May 13, 2021

ROCKVILLE, Md. and BEIJING, May 11, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and...

6 months ago - PRNewsWire

3 Hot Penny Stocks To Buy With Analysts Expecting Up To 383%

Penny stocks to buy according to top Wall Street analysts The post 3 Hot Penny Stocks To Buy With Analysts Expecting Up To 383% appeared first on Penny Stocks to Buy, Picks, News and Information | Penny...

Other symbols:AVGRMARK
7 months ago - PennyStocks

CASI Pharmaceuticals Announces Full Year 2020 Financial Results

ROCKVILLE, Md. and BEIJING, March 30, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics a...

8 months ago - PRNewsWire

Why CASI Pharmaceuticals Is Crashing Today

Investors don't like that the company is hitting up the market for more cash.

8 months ago - The Motley Fool

CASI Pharmaceuticals Announces Pricing Of $32,500,000 Public Offering Of Common Stock

ROCKVILLE, Md. and BEIJING, March 24, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics a...

8 months ago - PRNewsWire

CASI Pharmaceuticals Announces Proposed Public Offering Of Common Stock

ROCKVILLE, Md. and BEIJING, March 23, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics a...

8 months ago - PRNewsWire